PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-27.70%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
No Data
No Data available this quarter, please select a different quarter.
1234.83%
Other expenses change of 1234.83% versus flat Healthcare costs. Walter Schloss would verify efficiency.
115.67%
Operating expenses change of 115.67% versus flat Healthcare costs. Walter Schloss would verify control.
115.67%
Total costs change of 115.67% versus flat Healthcare costs. Walter Schloss would verify control.
719.71%
Interest expense change of 719.71% versus flat Healthcare costs. Walter Schloss would verify control.
No Data
No Data available this quarter, please select a different quarter.
-115.67%
EBITDA decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-115.67%
Operating income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
115.67%
Other expenses change of 115.67% versus flat Healthcare. Walter Schloss would verify control.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
133.51%
Tax expense change of 133.51% versus flat Healthcare. Walter Schloss would verify strategy.
-133.51%
Net income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-132.80%
EPS decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-132.80%
Diluted EPS decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.